WO2002061083A1 - Nouvelle proteine de recepteur couple aux proteines g et son adn - Google Patents

Nouvelle proteine de recepteur couple aux proteines g et son adn Download PDF

Info

Publication number
WO2002061083A1
WO2002061083A1 PCT/JP2002/000635 JP0200635W WO02061083A1 WO 2002061083 A1 WO2002061083 A1 WO 2002061083A1 JP 0200635 W JP0200635 W JP 0200635W WO 02061083 A1 WO02061083 A1 WO 02061083A1
Authority
WO
WIPO (PCT)
Prior art keywords
protein
same
novel
coupled receptor
dna
Prior art date
Application number
PCT/JP2002/000635
Other languages
English (en)
Japanese (ja)
Inventor
Keiji Iwamoto
Shuji Sato
Yasushi Shintani
Original Assignee
Takeda Chemical Industries, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries, Ltd. filed Critical Takeda Chemical Industries, Ltd.
Publication of WO2002061083A1 publication Critical patent/WO2002061083A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention concerne une nouvelle protéine de récepteur couplé aux protéines G contenant une séquence d'acides aminés identique ou sensiblement identique à la séquence d'acides aminés représentée par SEQ ID NO:1, un polynucléotide codant pour celle-ci, etc. Cette protéine d'origine humaine et l'ADN codant pour celle-ci peuvent être utilisés (1) pour déterminer un ligand associé à ladite protéine, (2) comme agents prophylactiques et/ou thérapeutiques destinés à des maladies en rapport avec l'hypofonction de cette protéine, (3) dans le criblage d'un composé (agoniste, antagoniste, etc.) capable de modifier les propriétés de liaison de cette protéine à un ligand, etc.
PCT/JP2002/000635 2001-01-30 2002-01-29 Nouvelle proteine de recepteur couple aux proteines g et son adn WO2002061083A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2001-21581 2001-01-30
JP2001021581 2001-01-30
JP2001102485 2001-03-30
JP2001-102485 2001-03-30

Publications (1)

Publication Number Publication Date
WO2002061083A1 true WO2002061083A1 (fr) 2002-08-08

Family

ID=26608518

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/000635 WO2002061083A1 (fr) 2001-01-30 2002-01-29 Nouvelle proteine de recepteur couple aux proteines g et son adn

Country Status (1)

Country Link
WO (1) WO2002061083A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003051925A1 (fr) * 2001-12-19 2003-06-26 Bayer Healthcare Ag Gpcr de type secretine humaine (latrophiline)
EP1383790A4 (fr) * 2001-03-28 2006-08-09 Applera Corp Recepteurs couples a des proteines g (gpcr) isolees, molecules d'acides nucleiques codant pour la proteine gpcr humaine et leurs utilisations

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000021999A1 (fr) * 1998-10-09 2000-04-20 Chugai Research Institute For Molecular Medicine, Inc. Nouveaux recepteurs couples a la proteine g
WO2000034473A2 (fr) * 1998-12-10 2000-06-15 Zymogenetics, Inc. Domaine transmembranaire 7 zsig56

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000021999A1 (fr) * 1998-10-09 2000-04-20 Chugai Research Institute For Molecular Medicine, Inc. Nouveaux recepteurs couples a la proteine g
WO2000034473A2 (fr) * 1998-12-10 2000-06-15 Zymogenetics, Inc. Domaine transmembranaire 7 zsig56

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1383790A4 (fr) * 2001-03-28 2006-08-09 Applera Corp Recepteurs couples a des proteines g (gpcr) isolees, molecules d'acides nucleiques codant pour la proteine gpcr humaine et leurs utilisations
WO2003051925A1 (fr) * 2001-12-19 2003-06-26 Bayer Healthcare Ag Gpcr de type secretine humaine (latrophiline)

Similar Documents

Publication Publication Date Title
WO2002084286A1 (fr) Procede de criblage
EP1717315A3 (fr) Protéines de liaison et récepteurs d'ostéoprotégérine
EP2368907A3 (fr) Anticorps anti-Abeta et leur utilisation
WO2007002261A3 (fr) Anticorps bloquant il-1$g(b) et leurs fragments
WO2003004622A3 (fr) Proteines humaines secretees
WO2005087811A3 (fr) Recepteurs des oestrogenes et procedes d'utilisation associes
EP2311955A3 (fr) Protéines liant l'ostéoprotégérine et leurs récepteurs.
CA2422622A1 (fr) Nouveaux acides nucleiques et polypeptides de baff-r
WO2003068959A1 (fr) Nouveau procede de criblage
IL175319A0 (en) Novel phosphate-binding protein, pharmaceutical compositions containing same and use thereof
WO2003002604A3 (fr) Nouveaux recepteurs couples a la proteine g et leurs sequences d'adn
WO2002102839A3 (fr) Nouveaux recepteurs couples a une proteine g et sequences d'adn de ceux-ci
WO2003018798A3 (fr) Recepteur couple aux proteines g nouvellement identifie et sequences d'adn de ce recepteur
WO2005072766A3 (fr) Peptides se liant aux proteines hsp90
WO2003018631A3 (fr) Homologues des recepteurs de nogo et leur utilisation
WO2002061083A1 (fr) Nouvelle proteine de recepteur couple aux proteines g et son adn
WO2005094453A3 (fr) La cospeptine, la cosmedine et leurs utilisations
WO2002044368A1 (fr) Nouvelles proteines du recepteur couple a la proteine g et leurs adn
EP1212340A4 (fr) 29 proteines associees au cancer humain
WO2007066018A3 (fr) Peptides qui peuvent se lier a la proteine nef et leurs applications pharmaceutiques
WO2003025179A1 (fr) Nouveau polypeptide, adn associe et utilisation de ce polypeptide
WO2003021262A1 (fr) Procede de criblage
WO2003082320A1 (fr) Nouveau procede de criblage
EP1584925A4 (fr) Nouveau procede de criblage
WO2003021263A1 (fr) Utilisation d'une proteine de recepteur couple a une proteine g

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP